Your browser doesn't support javascript.
Side Effects Reported by Jordanian Healthcare Workers Who Received COVID-19 Vaccines.
Abu-Hammad, Osama; Alduraidi, Hamza; Abu-Hammad, Shaden; Alnazzawi, Ahmed; Babkair, Hamzah; Abu-Hammad, Abdalla; Nourwali, Ibrahim; Qasem, Farah; Dar-Odeh, Najla.
  • Abu-Hammad O; College of Dentistry, Taibah University, Al Madinah Al Munawara 43353, Saudi Arabia.
  • Alduraidi H; School of Dentistry, University of Jordan, Amman 11942, Jordan.
  • Abu-Hammad S; School of Nursing, University of Jordan, Amman 11942, Jordan.
  • Alnazzawi A; Comprehensive Amman Healthcare Center, Amman 11192, Jordan.
  • Babkair H; College of Dentistry, Taibah University, Al Madinah Al Munawara 43353, Saudi Arabia.
  • Abu-Hammad A; College of Dentistry, Taibah University, Al Madinah Al Munawara 43353, Saudi Arabia.
  • Nourwali I; School of Medicine, University of Jordan, Amman 11942, Jordan.
  • Qasem F; College of Dentistry, Taibah University, Al Madinah Al Munawara 43353, Saudi Arabia.
  • Dar-Odeh N; University of Jordan Hospital, Amman 11942, Jordan.
Vaccines (Basel) ; 9(6)2021 Jun 01.
Article in English | MEDLINE | ID: covidwho-1259632
ABSTRACT
Background Distribution of COVID-19 vaccines has been surrounded by suspicions and rumors making it necessary to provide the public with accurate reports from trustworthy experts such as healthcare professionals. Methods We distributed a questionnaire in Jordan among physicians, dentists and nurses who received a COVID-19 vaccine to explore the side effects (SE) they encountered after the first or the second dose of one of three vaccines namely AstraZeneca Vaxzevria (AZ), Pfizer-BioNTeck (PB), and SinoPharm (SP) vaccines. Results A total of 409 professionals participated. Approximately 18% and 31% of participants reported no SE after the first dose and second dose, respectively. The remainder had mostly local side effects related to injection site (74%). Systemic side effects in the form of fatigue (52%), myalgia (44%), headache (42%), and fever (35%) prevailed mainly after the first dose. These were significantly associated with AZ vaccine, and age ≤ 45 years (p = 0.000 and 0.01, respectively). No serious SE were reported. Conclusions We can conclude that SE of COVID-19 vaccines distributed in Jordan are within the common range known so far for these vaccines. Further studies are needed to include larger sample size and longer follow-up period to monitor possible serious and long-term SE of the vaccines.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Vaccines Language: English Year: 2021 Document Type: Article Affiliation country: Vaccines9060577

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Vaccines Language: English Year: 2021 Document Type: Article Affiliation country: Vaccines9060577